Latest News

Host Hotels & Resorts (HST) is back in focus after selling two resort properties for US$1.1b and outlining plans to recycle those proceeds into shareholder returns, acquisitions, and portfolio reinvestment. See our latest analysis for Host Hotels & Resorts. At a share price of US$19.23, Host Hotels & Resorts has seen short term share price pressure, with a 1 day return of 3.66% decline and a 7 day return of 1.84% decline. At the same time, a 90 day share price return of 12.46% and a 1 year...

Disc Medicine, Inc. reported full-year 2025 results showing a net loss of US$212.18 million, with basic loss per share from continuing operations of US$6.01, both higher than the prior year, and also filed a US$108.71 million common stock shelf registration related to its employee stock ownership plan. This combination of a larger annual loss and a sizeable ESOP-related shelf registration filing raises fresh questions about the company’s funding needs and capital structure priorities. With...

Recently, Smurfit Westrock raised recycled containerboard prices in Europe by €100 per metric ton, prompting expectations that peers such as International Paper could also benefit from a firmer pricing backdrop across the sector. This move underscores how pricing decisions by major European producers can ripple across global packaging markets, potentially influencing margin resilience and capacity discipline for International Paper. We’ll now examine how the prospect of wider containerboard...

Höegh Autoliners (OB:HAUTO) has drawn fresh attention after reporting mixed fourth quarter and full year 2025 results, with higher sales set against weaker profitability, and confirming a cash dividend alongside an upcoming investor conference appearance. See our latest analysis for Höegh Autoliners. Against this mixed earnings backdrop, Höegh Autoliners’ share price at NOK132.5 reflects a strong 30 day share price return of 22.35% and 90 day return of 37.81%. The 1 year total shareholder...

Dividend proposal and earnings results set the tone for Xinyi Glass Xinyi Glass Holdings (SEHK:868) has drawn investor attention after reporting full year 2025 earnings, together with a proposed final cash dividend of HK$0.215 per share that will go to a shareholder vote in May. See our latest analysis for Xinyi Glass Holdings. The latest earnings release and dividend proposal have come alongside a strong run in the share price, with a 90 day share price return of 20.89% and year to date...

Akeso (SEHK:9926) is back in focus after presenting long term survival data for its bispecific antibody cadonilimab in advanced cervical cancer and announcing a new glioblastoma combo trial collaboration with INOVIO. See our latest analysis for Akeso. Akeso shares closed at HK$107.3 after a 5.2% 1 day share price return. While the 30 day share price return of 6.34% contrasts with a 13.75% decline over 90 days, the 47.19% 1 year total shareholder return and 173.03% 3 year total shareholder...

Broadstone Net Lease (BNL) has been busy, adding two build-to-suit projects totaling about $62.1 million, closing a $350 million senior notes offering, and seeing its CFO increase his personal shareholding. See our latest analysis for Broadstone Net Lease. Those new build-to-suit commitments, the $350 million senior notes issuance and recent guidance sit against a 9.7% year to date share price return and a 20.8% 1 year total shareholder return, with shorter term momentum cooling slightly...

Autoliv, Inc. recently renewed its EUR 3,000 million guaranteed euro medium term note programme and appointed long‑time insider Monika Grama as Chief Financial Officer and Executive Vice President, Finance, effective April 1, 2026, succeeding outgoing CFO Fredrik Westin. The combination of refreshed funding flexibility through the EMTN programme and a new CFO with deep EMEA operational finance experience may influence how investors assess Autoliv’s financial policy and capital allocation...

Piper Sandler Companies recently expanded its healthcare investment banking franchise by appointing Jason Arnold as a managing director and naming Aamer Naseer global head of life sciences outsourcing and B2B medical technology, strengthening coverage across life science tools, diagnostics and medical devices. These hires deepen Piper Sandler’s sector expertise just as many investors are watching how specialized healthcare advisory capabilities could influence future fee opportunities and...

Pentair stock snapshot and recent performance Pentair (PNR) has been on many watchlists after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months despite a positive 1 year total return. See our latest analysis for Pentair. At a share price of $92.17, Pentair’s recent 1 day, 7 day and 90 day share price returns have been negative, while its 1 year and 3 year total shareholder returns remain positive, suggesting shorter term...

Knight-Swift Transportation Holdings (KNX) is back in focus after recent trading left the stock with mixed short term moves, including a 1-day decline and a negative month, alongside a positive past 3 months. See our latest analysis for Knight-Swift Transportation Holdings. At a share price of $56.87, Knight-Swift’s recent 1-day and 7-day share price declines sit against an 11.49% 3-month share price return and a 22.54% 1-year total shareholder return. This suggests longer term momentum has...

The recent US jobs report, which showed an unexpected decline in employment and roughly 30,000 restaurant and bar jobs lost, has pressured sentiment around Darden Restaurants (DRI) as investors reassess consumer discretionary spending. See our latest analysis for Darden Restaurants. The share price reaction to the weak jobs data comes after a 12.95% 90 day share price return that has now cooled, leaving Darden at US$203.18 with 7.51% 1 year total shareholder return and a much stronger 55.63%...

Zymeworks Inc. has released its fourth quarter and full-year 2025 results, reporting a net loss of US$41.21 million for the quarter and US$81.13 million for the year, alongside basic and diluted loss per share from continuing operations of US$0.55 for the quarter and US$1.08 for the year. On the same day, the company also filed a US$79.29 million shelf registration for 3,404,536 common shares under an ESOP-related offering, highlighting both ongoing capital needs and an increased emphasis on...

Apellis Pharmaceuticals, Inc. announced that Mikael Dolsten, M.D., Ph.D., former Pfizer chief scientific officer, joined its board of directors on March 1, 2026, adding decades of pharmaceutical R&D leadership to the company. Dolsten’s track record overseeing the regulatory approval of more than 36 medicines and vaccines may influence how investors assess Apellis’s ability to advance and commercialize its pipeline. Next, we’ll examine how Dolsten’s board appointment could interact with...

Why PARK24’s latest quarter is getting investor attention PARK24 (TSE:4666) just released first quarter results to January 31, 2026, with sales of ¥106,549 million and net income of ¥5,806 million, both higher than the same period a year earlier. Basic earnings per share from continuing operations rose to ¥34.02 from ¥30.35, while diluted EPS reached ¥31.38 compared with ¥27.73. These figures give investors fresh data points for reassessing the stock. See our latest analysis for...

Technology One, a major Australian enterprise software provider, was recently removed from the S&P/ASX 50 index after S&P Dow Jones Indices’ March 2026 quarterly rebalance, while Hyperion Asset Management reduced its position below the substantial holding threshold. Together, the index exclusion and shift in institutional ownership could alter Technology One’s visibility among passive funds and reshape perceptions of its shareholder base. We’ll now explore how Technology One’s removal from...

Idorsia (SWX:IDIA) is back on watch for investors after a recent stretch of weak share performance, with the stock showing negative moves over the past week, month and past 3 months. See our latest analysis for Idorsia. At a share price of CHF3.53, Idorsia’s recent share price returns show pressure in the short term, including a 1 day decline of 3.55% and a year to date drop of 13.05%. In contrast, the 1 year total shareholder return of just over 3x and the deeply negative 3 and 5 year total...

In recent months, PC Connection, Inc. reported flat year-on-year Q4 revenue that fell short of analyst expectations amid sector-wide hardware and supply chain headwinds. At the same time, the company raised its quarterly dividend and saw a sharp drop in short interest, developments that may signal improving confidence from both management and investors despite operational challenges. Next, we’ll examine how the dividend increase shapes PC Connection’s investment narrative around cash...

Niterra Co., Ltd. has announced board-approved leadership changes effective April 1, 2026, with Keiji Suzuki becoming Representative Director and President and Takeshi Kawai moving to Representative Director and Chairman, while former Chairman Shinichi Odo transitions to Executive Advisor after retiring from the board in June 2026. The appointment of long-time engineer and internal leader Suzuki to the top executive role highlights a continued emphasis on technical expertise at the core of...

Why today’s sector jitters hit Walker & Dunlop Investor concern around private credit exposure, following Western Alliance Bancorporation’s loan write off, fed into fresh volatility for Walker & Dunlop (WD), even though the news is focused on sector risk rather than company specific developments. See our latest analysis for Walker & Dunlop. The 1 day share price return of 4.59% decline at a last close of $48.19 comes after a 7 day share price return of 4.74%, but a 30 day share price return...

In February 2026, Vaxcyte, Inc. reported a full-year 2025 net loss of US$766.63 million and completed a US$408.1 million follow-on equity offering, while also filing an additional US$500 million at-the-market program and a US$473.86 million shelf registration related to employee stock plans. These moves collectively highlight Vaxcyte’s reliance on equity financing to support its vaccine pipeline while absorbing widening losses, a pattern that can influence how investors assess funding risk...

In February 2026, Agilent Technologies reported first-quarter 2026 sales of US$1,798 million, with net income of US$305 million, and raised full-year 2026 revenue guidance to a range of US$7.30 billion to US$7.50 billion while issuing new second-quarter revenue guidance of US$1,790 million to US$1,820 million. Management’s decision to increase full-year revenue guidance while first-quarter earnings per share were slightly lower than a year earlier highlights confidence in cost control and...

Crown Castle (CCI) has been back in focus after fourth quarter 2025 results topped analyst estimates, followed by 2026 guidance and plans to sell its small cell and fiber businesses later this year. See our latest analysis for Crown Castle. The recent earnings beat, new 2026 guidance and the plan to sell the small cell and fiber businesses have coincided with an 11.81% 1-month share price return from Crown Castle, even though the 1-year total shareholder return of a 2.70% decline and 5-year...

Earnings and dividend decisions put Hong Kong Exchanges and Clearing (SEHK:388) in focus Hong Kong Exchanges and Clearing (SEHK:388) is on investors’ radar after reporting full year 2025 results with revenue of HK$29,161 million and net income of HK$17,754 million, alongside a higher second interim dividend of HK$6.52 per share. See our latest analysis for Hong Kong Exchanges and Clearing. The latest earnings, higher second interim dividend and upcoming board refresh arrive as the shares...